ATXI   $2.17  8.50% Market Closed After Close 2.1016 -3.15%

Avenue Therapeutics Inc
Last Events:

2023-08-09 Signal in MACD changed from bearish recovery to bearish weakening. Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: signal line crossed the middle level.

2023-08-09 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-06 Trend pattern changed from канал to расширяющаяся формация.

2023-08-06 Signal in Stochastic changed from bearish weakening to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.

2023-08-06 Signal in MACD changed from bearish weakening to bearish recovery. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: signal line crossed the middle level.

2023-08-06 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-06 Trend Power changed from almost flat to slow.

2023-08-05 Signal in Stochastic changed from bearish recovery to bearish weakening. The stochastic indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: main and signal line crossing.


Current temperature: 2.40
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 1
Target Price Mean 12.00
Mean unverified/preliminary 12.00 / 12.00
Target Price Low / High 12.00 / 12.00
Median / STD DEV 12.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy ActivelyBuy None
rsi Sell ActivelyBuy None
macd None ActivelyBuy None
stoch ActivelyBuy None None
ma20 Buy ActivelyBuy None
ma50 ActivelyBuy None None
ma100 Buy ActivelyBuy None
Candlestick PatternOct. 18, 2024 Three Stars -
ISIN US05360L4032
ceo Dr. Alexandra MacLean M.D.
Website https://www.avenuetx.com
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida.